Tandem Diabetes Care Inc (NAS:TNDM)
$ 33.81 1.71 (5.33%) Market Cap: 2.11 Bil Enterprise Value: 1.98 Bil PE Ratio: 0 PB Ratio: 8.85 GF Score: 82/100

Tandem Diabetes Care Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 01:15AM GMT
Release Date Price: $40.41 (-3.79%)
Edwin Zhang

Hello. Good evening. Could the audience please take a seat as we are beginning the next portion of our presentation?

So welcome, ladies and gentlemen, to the 41st Annual JPMorgan Healthcare Conference. My name is Edwin Zhang. I'm a part of the health care team with JPMorgan. And today, we're here to hear about the presentation from the Tandem Diabetes Care team. Our presenter is John Sheridan, who is the CEO of Tandem. Following that, we also have Leigh Vosseller, who is the CFO; and Susan Morrison, who is the EVP and CAO of the company. So please join me in welcoming them to the stage.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks, Ed. Ed, real quick. Where is the flipper for the slides? Is this it here? Okay. Great. Thank you.

Well, good evening, everybody. It's nice to be here. This is our first visit to JPMorgan as a public company. I just want to start off by saying that we released the 4Q and 2Q '22 earnings last night. And in them, there was a notification -- we had GAAP and non-GAAP results.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot